Ab Studio designed antibodies are at clinical stages! GB261, an Fc-Function Enabled and CD3 Affinity De-Tuned CD20/CD3 Bispecific Antibody designed by Ab Studio shows promising new results published in ASH's annual meeting.   Click here for more information.


Using our proven technology of computer-design and on-bench validation, SEND US YOUR PROTEIN SEQUENCE and we will provide a drug candidate OFFERING IMPROVED BALANCE OF SAFETY, EFFICACY, AND MANUFACTURABILITY.  


Case Studies

Tri-specific antibody for COVID-19

Read More

Researchers Show How COVID-19 Virus Triggers Immune Signaling “Storm”

Read More

Serial internalization
antibody development

Read More

Novel "imbalanced"
CSA bi-specific antibody

Read More

3541 Investment Blvd. Suite 3,
Hayward, CA 94545 USA